Peloton Therapeutics Finds $52.4M

Dallas-based Peloton Therapeutics recently raised $52.4M in a Series D funding round, in a funding which was announced earlier in September. The funding came from Foresite Capital Management, Remeditex LLC, The Column Group, Tichenor Ventures LLC, Topspin Fund LP, and Nextech Invest Ltd. Foresite Capital Management gains an observer on the company's board as part of the funding. Peloton Therapeutics is developing small molecule cancer therapies, and is led by John A. Josey, Ph.D. More information »